DescriptionSizeFormat
Author final version139 KBAdobe Acrobat PDFView/Open

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/805724

Title
Metabolic approaches to treatment of melanoma
Author/Creator
Hersey, Peter;  Watts, Ralph Neal;  Zhang, Xu Dong;  Hackett, John
Institution
The University of Newcastle. Faculty of Health, School of Medicine and Public Health
Description
Purpose: Lactate dehydrogenase (LDH) levels in blood of patients with melanoma have proven to be an accurate predictor of prognosis and response to some treatments. Exclusion of patients with high LDH levels from many trials of new treatments has created a need for treatments aimed at patients with high LDH levels. This article reviews the metabolic basis for the association of LDH with prognosis and the treatment initiatives that may be successful in this patient group. Experimental Design: Review of current literature on the topic. Results: A number of new treatment initiatives based on manipulation of metabolic pathways in melanoma cells are now available and await evaluation in well-designed clinical trials. Conclusions: Different cancers may require different metabolic approaches for effective treatment. In view of the high rate of glycolysis in most melanoma cells, approaches based on inhibition of acid excretion from the cells seem particularly attractive.
Relation
Clinical Cancer Research Vol. 15, Issue 21, p. 6490-6494
Publisher Link
http://dx.doi.org/10.1158/1078-0432.CCR-09-0251
Date
2009
Publisher
American Association for Cancer Research
Keyword(s)
melanoma;  omeprazole;  N-acetyl cysteine;  LDH
Resource Type
journal article
Identifier
http://hdl.handle.net/1959.13/805724
Identifier
ISSN:1078-0432
Reviewed
Reviewed
Full Text
Full Text
 
Image Thumbnail
48 Visitors 53 Hits 2 Downloads
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Clinical Cancer Research"
 
OR